HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olivier Jordan Selected Research

N-(3-pyridyl)-3-phenylsuccinimide

1/2018Nanocrystals of a potent p38 MAPK inhibitor embedded in microparticles: Therapeutic effects in inflammatory and mechanistic murine models of osteoarthritis.
1/2018Nanocrystal-Polymer Particles: Extended Delivery Carriers for Osteoarthritis Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olivier Jordan Research Topics

Disease

9Osteoarthritis
03/2022 - 10/2015
8Neoplasms (Cancer)
10/2018 - 03/2007
5Wounds and Injuries (Trauma)
03/2022 - 05/2020
3Hyperplasia
05/2022 - 01/2016
3Pain (Aches)
03/2022 - 06/2015
3Inflammation (Inflammations)
11/2020 - 06/2015
3Arthritis (Polyarthritis)
01/2018 - 01/2009
2Aneurysm (Aneurysms)
03/2007 - 02/2006
1Tendinopathy (Tendonitis)
12/2021
1Disease Progression
01/2021
1Infections
09/2020
1Wound Infection (Wound Infections)
09/2020
1Liver Neoplasms (Liver Cancer)
10/2018
1Hepatocellular Carcinoma (Hepatoma)
09/2017
1Necrosis
09/2017
1Chronic Disease (Chronic Diseases)
10/2016
1Pathologic Constriction (Stenosis)
12/2013
1Hyperthermia
05/2009
1Arteriovenous Malformations (Arteriovenous Malformation)
03/2007

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
05/2022 - 03/2007
5Hyaluronic Acid (Hyaluronan)IBA
03/2022 - 10/2015
4HydrogelsIBA
03/2022 - 02/2010
4PolymersIBA
09/2020 - 02/2006
3Atorvastatin (Lipitor)FDA Link
05/2022 - 01/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2021 - 01/2018
2Adenosine Monophosphate (AMP)IBA
09/2020 - 05/2020
2Antimicrobial PeptidesIBA
09/2020 - 05/2020
2Sunitinib (Sutent)FDA Link
10/2018 - 01/2016
2AntigensIBA
01/2018 - 01/2009
2N-(3-pyridyl)-3-phenylsuccinimideIBA
01/2018 - 01/2018
2p38 Mitogen-Activated Protein KinasesIBA
01/2018 - 06/2015
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2018
2Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
02/2010 - 02/2006
2SolventsIBA
02/2010 - 03/2007
2Adrenal Cortex Hormones (Corticosteroids)IBA
03/2009 - 01/2009
1Bulk DrugsIBA
12/2021
1Celecoxib (Celebrex)FDA Link
11/2020
1AS resinIBA
05/2020
1Dendrimers (Dendrons)IBA
05/2020
1SU 12662IBA
10/2018
1Angiogenesis InhibitorsIBA
10/2018
1Therapeutic UsesIBA
01/2018
1SolutionsIBA
01/2018
1PH 797804IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
10/2016
1Delayed-Action PreparationsIBA
10/2016
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2016
1Tyrosine Kinase InhibitorsIBA
03/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2013
1AlginatesIBA
02/2010
1ethylene-vinyl alcohol copolymerIBA
02/2010
1GelsIBA
02/2010
1Silicon Dioxide (Silica)FDA LinkGeneric
05/2009
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2009
1dexamethasone acetateFDA Link
03/2009
1SuspensionsIBA
01/2009
1IodineIBA
02/2006
1Polyvinyl AlcoholIBA
02/2006

Therapy/Procedure

6Therapeutics
03/2022 - 05/2009
4Microspheres (Microsphere)
10/2018 - 05/2009
4Injections
10/2016 - 03/2007
2Viscosupplementation
03/2022 - 10/2015
2Intra-Articular Injections
01/2018 - 10/2015
2Induced Hyperthermia (Thermotherapy)
02/2010 - 05/2009
1Intra-Arterial Injections
09/2017